Stock FME FRESENIUS MEDICAL CARE AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials Fresenius Medical Care AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Xetra
Other stock markets
 11:35:12 2024-05-03 am EDT 		5-day change 1st Jan Change
39.26 EUR -2.34% Intraday chart for Fresenius Medical Care AG +4.92% +3.42%
May. 03 European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower MT
May. 03 FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan reaffirms its Sell rating ZD

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 19,672 19,974 16,742 8,970 11,138 11,519 - -
Enterprise Value (EV) 1 32,447 31,272 28,580 20,909 21,898 21,353 20,559 19,852
P/E ratio 16.7 x 17.2 x 17.3 x 13.3 x 22.3 x 16.3 x 12 x 10.3 x
Yield 1.82% 1.96% 2.36% 3.66% 3.13% 2.75% 3.28% 3.85%
Capitalization / Revenue 1.13 x 1.12 x 0.95 x 0.46 x 0.57 x 0.59 x 0.57 x 0.54 x
EV / Revenue 1.86 x 1.75 x 1.62 x 1.08 x 1.13 x 1.09 x 1.01 x 0.93 x
EV / EBITDA 8.4 x 7.65 x 8.22 x 6.24 x 7.02 x 6.34 x 5.54 x 5.11 x
EV / FCF 22.5 x 9.78 x 17.2 x 14.1 x 11.2 x 11.4 x 10.7 x 12.2 x
FCF Yield 4.44% 10.2% 5.81% 7.08% 8.95% 8.75% 9.37% 8.2%
Price to Book 1.67 x 1.78 x 1.32 x 0.64 x 0.75 x 0.81 x 0.78 x 0.76 x
Nbr of stocks (in thousands) 298,249 292,869 292,994 293,413 293,413 293,413 - -
Reference price 2 65.96 68.20 57.14 30.57 37.96 39.26 39.26 39.26
Announcement Date 2/20/20 2/23/21 2/22/22 2/21/23 2/20/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 17,477 17,859 17,619 19,398 19,454 19,621 20,347 21,278
EBITDA 1 3,863 4,090 3,476 3,350 3,121 3,369 3,710 3,886
EBIT 1 2,270 2,304 1,852 1,512 1,369 1,685 2,045 2,324
Operating Margin 12.99% 12.9% 10.51% 7.79% 7.04% 8.59% 10.05% 10.92%
Earnings before Tax (EBT) 1 1,841 1,936 1,572 1,219 1,033 1,273 1,633 1,929
Net income 1 1,200 1,164 969.3 673.4 499 693.5 969.2 1,177
Net margin 6.87% 6.52% 5.5% 3.47% 2.57% 3.53% 4.76% 5.53%
EPS 2 3.960 3.960 3.310 2.300 1.700 2.410 3.281 3.821
Free Cash Flow 1 1,442 3,197 1,660 1,480 1,960 1,869 1,925 1,629
FCF margin 8.25% 17.9% 9.42% 7.63% 10.08% 9.53% 9.46% 7.65%
FCF Conversion (EBITDA) 37.33% 78.17% 47.76% 44.18% 62.8% 55.48% 51.9% 41.92%
FCF Conversion (Net income) 120.18% 274.57% 171.26% 219.78% 392.79% 269.53% 198.66% 138.38%
Dividend per Share 2 1.200 1.340 1.350 1.120 1.190 1.080 1.288 1.511
Announcement Date 2/20/20 2/23/21 2/22/22 2/21/23 2/20/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 4,441 4,647 4,548 4,757 5,096 4,997 4,704 4,825 4,936 4,988 4,732 4,799 4,948 5,028 -
EBITDA 1 907.5 895.4 767 763 973.6 846.6 698.8 790.8 778.3 854 759.9 855.4 898 766.6 -
EBIT 1 504.7 449.2 348 341 471.6 351.9 260.9 357 324 428 350.2 427 461.4 496.2 -
Operating Margin 11.36% 9.67% 7.65% 7.17% 9.25% 7.04% 5.55% 7.4% 6.56% 8.58% 7.4% 8.9% 9.33% 9.87% -
Earnings before Tax (EBT) 436.2 382.4 278.6 268.9 395.2 - - - - - - - - - -
Net income 273 228.7 157 147 230.1 138.8 86.36 140 84 188 - - - - -
Net margin 6.15% 4.92% 3.45% 3.09% 4.52% 2.78% 1.84% 2.9% 1.7% 3.77% - - - - -
EPS 2 0.9300 0.7800 0.5400 0.5000 0.7800 0.4800 0.2900 0.4800 0.2900 0.6400 0.0400 - - - -
Dividend per Share 2 - 1.350 - - - 1.120 - - - 1.190 - - - 0.7387 -
Announcement Date 11/2/21 2/22/22 5/4/22 7/28/22 10/31/22 2/21/23 5/9/23 8/2/23 11/1/23 2/20/24 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 12,775 11,298 11,838 11,939 10,760 9,834 9,040 8,333
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.307 x 2.762 x 3.406 x 3.564 x 3.448 x 2.919 x 2.437 x 2.145 x
Free Cash Flow 1 1,442 3,197 1,660 1,480 1,960 1,869 1,925 1,629
ROE (net income / shareholders' equity) 11.5% 11.7% 7.37% 5.05% 4.99% 5.65% 6.82% 7.43%
ROA (Net income/ Total Assets) 4.06% 3.6% 2.93% 1.92% 2.17% 2.09% 2.78% 3.51%
Assets 1 29,589 32,308 33,038 35,060 22,998 33,235 34,816 33,574
Book Value Per Share 2 39.50 38.30 43.30 47.70 50.50 48.30 50.40 51.90
Cash Flow per Share 2 8.480 14.40 8.500 7.390 8.960 8.010 8.350 9.150
Capex 1 1,125 1,036 829 687 669 855 926 1,023
Capex / Sales 6.44% 5.8% 4.71% 3.54% 3.44% 4.36% 4.55% 4.81%
Announcement Date 2/20/20 2/23/21 2/22/22 2/21/23 2/20/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.26 EUR
Average target price
39.16 EUR
Spread / Average Target
-0.25%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+3.42% 12.62B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.70% 81.68B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-29.20% 69.23B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+9.72% 29.08B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-11.43% 16.88B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.43% 16.85B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-0.31% 15.15B
DAVITA INC. Stock DaVita Inc.
+28.34% 12.47B
PURE HEALTH HOLDING Stock Pure Health Holding
-30.70% 11.89B
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
-6.75% 11.68B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. FME Stock
  4. Financials Fresenius Medical Care AG